Impax Laboratories, Inc. is preparing its answer to Eli Lilly and Company’s patent infringement complaint, according to its Form 10- Q/A filed with the U.S. Securities and Exchange Commission dated…
Eli Lilly and Co.’s lawsuit against Teva Pharmaceuticals Inc. in the U.S. District Court for the Southern District of Indiana for the infringement of its Evista(R) patent is scheduled for…
Eli Lilly and Co. continues to defend against the various legal challenges to its Zyprexa(R) patents in Europe, on a country-by- country basis.
The Company has received challenges to Zyprexa patents…
Trial is anticipated as early as December 2009, for the remaining defendants in Eli Lilly and Co.’s lawsuit alleging the infringement of the U.S. patent that covers the Company’s Strattera(R)…
Eli Lilly and Co.’s appeal from the September 2007 final judgment indicating that Ariad Pharmaceuticals Inc.’s claims are patentable, valid, and enforceable remains pending.
In June 2002, Ariad Pharmaceuticals Inc., the…
Eli Lilly and Co. is pursuing litigation against Teva Parenteral Medicines, Inc. and APP Pharmaceuticals, LLC over the infringement of the Alimta(R) compound patent in the U.S. District Court for…
Eli Lilly and Co. continues to pursue main infringement actions against all generic companies marketing generic olanzapine products in Germany, according to the Company’s latest Quarterly Reports filed with the…
Eli Lilly and Co. is reviewing the allegations by generic drug manufacturers that the Company’s patents that relate to the Cymbalta(R) product are either invalid or not infringed.
The Company has…
Eli Lilly and Co.’s Gemzar(R) patents infringement lawsuit against Sicor Pharmaceuticals, Inc. has been scheduled for trial in July 2009.
Sicor Pharmaceuticals, Inc., Mayne Pharma (USA) Inc., and Sun Pharmaceutical Industries…
Eli Lilly and Co. continues to pursue lawsuits against Novopharm Ltd., Pharmascience, Sandoz Inc., Nu-Pharm, and Genpharm for the infringement of its Zyprexa(R) patents in Canada.
In 2005, Apotex Inc. and…